Anthem may be calling off its $48 billion bid for rival health insurer Cigna after facing stiff regulatory challenges, according to a report from the New York Post.
The Post said it had learned that Anthem “appears ready to walk away from the deal,” though the company officially says it is not currently weighing a termination of the merger.
US antitrust regulators have been skeptical of the deal and are concerned that the acquisition would lead to too muchindustry consolidation, resulting in less competition and higher premium prices for customers.
The deal would combine the No. 2 and No. 4 health insurers in the US, creating a behemoth with 53 million customers in commercial, government, consumer, and other kinds of health insurance plans.
Full Content: NY Post
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile’s Acquisition of Ka’ena Corporation Receives FCC Approval
Apr 26, 2024 by
CPI
UK Regulator Announces Two New Senior Executive Appointments
Apr 26, 2024 by
CPI
Paramount Global and Skydance Media Near Merger Deal, Eyeing CEO Change
Apr 26, 2024 by
CPI
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI